AMGEN INC.

Lobbying client · District of Columbia · filed 2025 to 2026

Biotechnology

$75,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (59026), not by name.

Firms hired 1

WASHINGTON ADVOCACY GROUP $75,000 6 filings

Reported by year 2 years

2026 $15,000 2 filings
2025 $60,000 4 filings

Issues lobbied 1

Health Issues 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

SENATE 6

Recent filings 6 total

2T

WASHINGTON ADVOCACY GROUP

2nd Quarter (Apr 1 - June 30) 2026 · Senate · $5,000 income · posted Jun 12, 2026

View → Q1

WASHINGTON ADVOCACY GROUP

1st Quarter (Jan 1 - Mar 31) 2026 · Senate · $10,000 income · posted Apr 22, 2026

View → Q4

WASHINGTON ADVOCACY GROUP

4th Quarter (Oct 1 - Dec 31) 2025 · Senate · $20,000 income · posted Jan 19, 2026

View → Q3

WASHINGTON ADVOCACY GROUP

3rd Quarter (July 1 - Sep 30) 2025 · Senate · $15,000 income · posted Oct 14, 2025

View → Q2

WASHINGTON ADVOCACY GROUP

2nd Quarter (Apr 1 - June 30) 2025 · Senate · $15,000 income · posted Jul 21, 2025

View → Q1

WASHINGTON ADVOCACY GROUP

1st Quarter (Jan 1 - Mar 31) 2025 · Senate · $10,000 income · posted Apr 20, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.